The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2164961
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08757277.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
Dates
Filing date:
25/06/2008
Grant date:
07/01/2015
EP Publication Date:
07/01/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/01/2015
EP B1 Publication Date:
07/01/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
24/06/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
01/06/2022
Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Historical Applicant/holder
From:
01/06/2022
To:
01/06/2022
Name:
ESBATech, a Novartis Company LLC
Address:
Wagistrasse 12, 8952, Schlieren, Switzerland (CH)
From:
07/01/2015
To:
01/06/2022
Name:
ESBATech, an Alcon Biomedical Research Unit LLC
Address:
Wagistrasse 21, 8952 SCHLIEREN, Switzerland (CH)
Domicile Holder
Name:
drs. C.M.A. Quintelier
From:
07/01/2015
Address:
KIRKPATRICK
32 Avenue Wolfers, B-1310, La Hulpe, Belgium (BE)